In fact, clinical studies revealed significantly low circulating adropin levels in patients with NAFLD, which indicated that adropin may involve in the pathophysiology of NAFLD [43, 44]. This evidence concerns the gene ENHO and metabolic dysfunction-associated steatotic liver disease.